These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 2166820)

  • 21. Protection against feline leukemia virus infection by use of an inactivated virus vaccine.
    Hoover EA; Perigo NA; Quackenbush SL; Mathiason-DuBard CK; Overbaugh JM; Kloetzer WS; Elder JH; Mullins JI
    J Am Vet Med Assoc; 1991 Nov; 199(10):1392-401. PubMed ID: 1666090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant feline herpesviruses expressing feline leukemia virus envelope and gag proteins.
    Cole GE; Stacy-Phipps S; Nunberg JH
    J Virol; 1990 Oct; 64(10):4930-8. PubMed ID: 2168977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo infection of marrow stromal fibroblasts by feline leukemia virus.
    Linenberger ML; Abkowitz JL
    Exp Hematol; 1992 Sep; 20(8):1022-7. PubMed ID: 1324184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The surface glycoprotein of feline leukemia virus isolate FeLV-945 is a determinant of altered pathogenesis in the presence or absence of the unique viral long terminal repeat.
    Bolin LL; Ahmad S; Lobelle-Rich PA; Ooms TG; Alvarez-Hernandez X; Didier PJ; Levy LS
    J Virol; 2013 Oct; 87(19):10874-83. PubMed ID: 23903838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of a human cytomegalovirus glycoprotein complex (gcI).
    Gretch DR; Gehrz RC; Stinski MF
    J Gen Virol; 1988 Jun; 69 ( Pt 6)():1205-15. PubMed ID: 2838571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glycosylation of the envelope glycoprotein from a polytropic murine retrovirus in two different host cells.
    Geyer H; Kempf R; Schott HH; Geyer R
    Eur J Biochem; 1990 Nov; 193(3):855-62. PubMed ID: 2174368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolation of a novel subgroup B feline leukemia virus from a cat infected with FeLV-A.
    Boomer S; Gasper P; Whalen LR; Overbaugh J
    Virology; 1994 Nov; 204(2):805-10. PubMed ID: 7941350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutations within a putative cysteine loop of the transmembrane protein of an attenuated immunodeficiency-inducing feline leukemia virus variant inhibit envelope protein processing.
    Burns CC; Poss ML; Thomas E; Overbaugh J
    J Virol; 1995 Apr; 69(4):2126-32. PubMed ID: 7884859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell-specific envelope glycosylation distinguishes FIV glycoproteins produced in cytopathically and noncytopathically infected cells.
    Poss ML; Dow SW; Hoover EA
    Virology; 1992 May; 188(1):25-32. PubMed ID: 1314453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular analysis and pathogenesis of the feline aplastic anemia retrovirus, feline leukemia virus C-Sarma.
    Riedel N; Hoover EA; Gasper PW; Nicolson MO; Mullins JI
    J Virol; 1986 Oct; 60(1):242-50. PubMed ID: 3018287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hematopoietic target cells of anemogenic subgroup C versus nonanemogenic subgroup A feline leukemia virus.
    Dean GA; Groshek PM; Mullins JI; Hoover EA
    J Virol; 1992 Sep; 66(9):5561-8. PubMed ID: 1323710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polypeptides of Mason-Pfizer monkey virus. II. Synthesis and processing of the env gene products.
    Bradac J; Hunter E
    Virology; 1986 Apr; 150(2):491-502. PubMed ID: 3083581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel intermediate in processing of murine leukemia virus envelope glycoproteins. Proteolytic cleavage in the late Golgi region.
    Bedgood RM; Stallcup MR
    J Biol Chem; 1992 Apr; 267(10):7060-5. PubMed ID: 1313032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of swainsonine and castanospermine on the sulfation of the oligosaccharide chains of N-linked glycoproteins.
    Merkle RK; Elbein AD; Heifetz A
    J Biol Chem; 1985 Jan; 260(2):1083-9. PubMed ID: 3918027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Abnormal processing of a recombinant feline leukemia virus envelope polyprotein and its interference with subgroup C virus infection.
    Bechtel MK; Stallcup MR; Bedgood RM; Corey JL; Pandey R; Roy-Burman P
    Virology; 1994 Jul; 202(1):329-38. PubMed ID: 8009844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of inhibitors of oligosaccharide processing on P0 protein synthesis and incorporation into PNS myelin.
    Smith ME
    J Neurochem; 1991 Aug; 57(2):655-64. PubMed ID: 1712832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.
    Weijer K; Pfauth A; van Herwijnen R; Jarrett O; Meloen RH; Tomee C; Osterhaus AD
    Vaccine; 1993; 11(9):946-56. PubMed ID: 7692683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of a putative receptor for subgroup A feline leukemia virus on feline T cells.
    Ghosh AK; Bachmann MH; Hoover EA; Mullins JI
    J Virol; 1992 Jun; 66(6):3707-14. PubMed ID: 1316477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathogenic and host range determinants of the feline aplastic anemia retrovirus.
    Riedel N; Hoover EA; Dornsife RE; Mullins JI
    Proc Natl Acad Sci U S A; 1988 Apr; 85(8):2758-62. PubMed ID: 2833751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Feline oncornavirus-associated cell membrane antigen: a viral and not a cellularly coded transformation-specific antigen of cat lymphomas.
    Vedbrat SS; Rasheed S; Lutz H; Gonda MA; Ruscetti S; Gardner MB; Prensky W
    Virology; 1983 Jan; 124(2):445-61. PubMed ID: 6186079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.